Advertisement
Advertisement
Trending on Dermatology Times
1
Once-Daily Zasocitinib Offers New Oral Option for Psoriasis
2
As AI Adoption Grows, Dermatologists Navigate Patient Misinformation
3
First-in-Class Oral Piclidenoson Reaches Pivotal Phase 3 Enrollment Milestone in Plaque Psoriasis
4
Combination Therapy Guides Acne Management Across Severity Levels
5